- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Article Processing Charges ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Recently Accepted Articles ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Cardiovascular Psychiatry and Neurology
Volume 2011 (2011), Article ID 469046, 10 pages
Effects of Neonatal Systemic Inflammation on Blood-Brain Barrier Permeability and Behaviour in Juvenile and Adult Rats
1Department of Pharmacology, University of Melbourne, Medical Building 181, Parkville VIC 3010, Australia
2Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford OX13QX, UK
3Institute of Stem Cell Research, Helmholtz Zentrum München, 85764 Neuherberg, Germany
Received 11 August 2010; Revised 9 January 2011; Accepted 18 January 2011
Academic Editor: Alon Friedman
Copyright © 2011 H. B. Stolp et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Several neurological disorders have been linked to inflammatory insults suffered during development. We investigated the effects of neonatal systemic inflammation, induced by LPS injections, on blood-brain barrier permeability, endothelial tight junctions and behaviour of juvenile (P20) and adult rats. LPS-treatment resulted in altered cellular localisation of claudin-5 and changes in ultrastructural morphology of a few cerebral blood vessels. Barrier permeability to sucrose was significantly increased in LPS treated animals when adult but not at P20 or earlier. Behavioural tests showed that LPS treated animals at P20 exhibited altered behaviour using prepulse inhibition (PPI) analysis, whereas adults demonstrated altered behaviour in the dark/light test. These data indicate that an inflammatory insult during brain development can change blood-brain barrier permeability and behaviour in later life. It also suggests that the impact of inflammation can occur in several phases (short- and long-term) and that each phase might lead to different behavioural modifications.
Human data related to disorders such as autism, schizophrenia, and cerebral palsy indicate that a period of infection/inflammation during specific stages of brain development may act as a triggering insult [1–4]. In animal experimental studies, inflammation induced during the early postnatal period in rodents has been associated with increased blood-brain barrier permeability , white matter damage [6–13], ventricular enlargement [9, 14], and reduced neuron numbers in regions of the hippocampus and cerebellum [15, 16]. In addition, in animals exposed to inflammation in utero or during early postnatal life, long-term behavioural alterations such as deficits in prepulse inhibition test [17, 18], motor behaviour , and learning and memory [19, 20] have also been reported. However, the biological mechanisms involved in these pathologies are still not understood. To date there are no studies that directly investigated possible links between changes in blood-brain barrier permeability and behavioural alterations in animals exposed to an inflammatory mediator during early stages of brain development.
In this study, we have investigated possible correlations between some behavioural tests and blood-brain barrier morphology and permeability in adolescent and adult rats that were exposed to a prolonged inflammatory stimulus (LPS-injections) as neonates. To examine possible cellular mechanisms behind the alteration in blood-brain barrier permeability, the distribution of claudin-5, a key tight junction protein shown to directly affect barrier permeability [21, 22], was visualised by immunocytochemistry and electron microscopy was used to study the ultrastructure of brain blood vessels in these animals.
2. Materials and Methods
2.1. Animal Model
All experiments were approved by the University of Melbourne Animal Ethics Committee according to NH&MRC guidelines. Sprague-Dawley rats were sourced from the Breeding Research Facility at University of Melbourne and all animals were kept under similar condition in standard animal cages with sawdust bedding, free access to food (Specialty feed rat pellets)/water, and under controlled environment (12 h day/light cycle, 20-21°C and 50–60% relative humidity). During the light period, the illumination in the room was >350 lux (1 meter above ground) and background noise due to air-conditioning was about 55 dB.
Newborn rats were given five 0.2 mg/kg intraperitoneal (i.p.) injections of lipopolysaccharide (LPS, E. coli 055:B5) or equal volume of sterile saline (control animals) at postnatal day 0 (P0), 2, 4, 6, and 8, to produce a prolonged period of inflammation over the postnatal period . Litters were marked and equally divided into saline- and LPS-treated cohorts, including both male and female animals. During the period of treatment (P0–P8), LPS-injected animals had a significantly lower body weight compared to saline-injected controls. At P8 LPS-treated pups weighed g compared to g for controls (mean ± SEM; for each group). The body weight was still lower at P20 in LPS-injected animals (controls g, g for LPS-treated animals; ***, for each group), whereas no significant difference was found in adults (controls g, LPS-treated animals g; , for each group).
Animals were left until either P20 or adulthood for behavioural testing; blood-brain barrier permeability measurements were made at P9 and P20 (we have previously published adult sucrose permeability data ), claudin-5 immunocytochemistry was performed at P9, P20 and adult; ultrastructural examination of cerebral blood vessels was carried out on adult material only.
2.2. Behavioural Tests
All behavioural tests were performed at the Integrative Neuroscience Facility, Howard Florey Institute. Animals were acclimatised to the facility for a week before testing and 1-2 day recovery periods were allowed between each set of tests. The first two tests were conducted at P20 (, 2 days following weaning) and in adult animals (), whereas the last two tests (Open field, Morris water maze) were carried out in adults only, as P20 animals were too young to cooperate. Different cohorts of animals were tested at P20 and as adults to avoid influences in adult responses due to previous exposure to behavioural testing conditions. Rats were tested in random order and under similar environmental conditions to those under which they were normally kept unless specifically stated below.
2.2.1. Prepulse Inhibition and Acoustic Startle Response
For this test the animal was placed in a 9 cm diameter cylinder on a movement-sensitive platform inside a sound-attenuating box with a background sound level of 70 dB. Over 40 minutes a programme of randomly ordered sound stimuli, with 25 second intervals, was given. These included the 115 dB, 40 msec startle stimuli either by itself or preceded by a 100 msec weak prepulse nonstartling stimulus at 74, 78, or 86 dB (i.e., 4, 8 and 16 dB above background), and no stimuli periods. The same programme of sound stimuli was used for each animal. The startle response (a jumping reflex that lasts for less than one second) was measured by STARTLE software.
2.2.2. Light/Dark Test
Animals were placed in a cm arena, divided into a light (750 lux) and dark (no light) half by a Perspex insert, with a Tru scan locomotor system (light sensors measuring movement in the vertical and horizontal planes) and Tru scan software for live data recording and analysis. After 10 minutes the session was stopped and the animal was returned to its cage. The movement of the animal was analysed including the latency of the first entry and number of entries into the light half.
2.2.3. Open Field Exploration Test
The general locomotor activity of the adult animals was determined in open field exploration. Animals were placed in a cm arena setup with a Tru scan locomotor system and Tru scan software for live data recording and analysis. After 1 hour the session was stopped and the animal returned to its cage. Analysis of movement, detected by the Tru Scan locomotor system, was conducted for horizontal and vertical planes as well as the movement of the animal along the margins or the centre of the arena.
2.2.4. Morris Water Maze
A circular water maze pool (2 m diameter) was filled to a depth of 30 cm with 25°C water and enough nontoxic paint to make the water opaque. A circular 15 cm diameter platform was submerged 1 cm below the water level in one quadrant of the pool. The animal was placed in the water in a random quadrant and allowed 2 minutes to find the platform. The time to find the platform was recorded. The animal was left for 30 seconds on the platform before being removed, dried and placed under a warming lamp before repeating the test with the same platform location, but the animal entering the pool in a different quadrant. The testing procedure was repeated daily until the animals showed no improvement in the time taken to find the platform. For a final test, the platform was removed and the animal was introduced to the pool for 1 minute. The frequency and duration the animal spent in the platform zone (the zone where the platform used to be) were measured.
2.3. Blood-Brain Barrier Permeability
Brain/plasma sucrose concentration ratios were measured as an index of blood-brain barrier permeability in animals that had been injected with either LPS or saline as neonates (see above). Due to the small size of P9 animals, different methods were used to estimate concentration ratios at younger (P9) and older (P20) ages ( for each age group and treatment).
In P9 animals, serial blood sampling is not possible therefore, in order to obtain proper steady state concentration ratios, nephrectomy was performed under isoflurane (3%) anaesthesia before an i.p. injection (6 μL/g body weight) of 1 μCi 14C-sucrose (Amersham, CFB146). Animals regained consciousness and were kept under a heat-lamp at 28°C. Three hours after the sucrose injection, when concentration ratios achieve a near to steady state level , the animals were terminally anaesthetised with halothane and blood and brains collected. Plasma was separated by centrifugation. The brain was divided into cerebral hemispheres, midbrain, cerebellum and brainstem and frozen before further processing.
In P20 rats serial blood sampling was possible, and was used to construct the plasma radioactivity curve following radiolabel injection . In anaesthetised animals, the left femoral vein and artery were cannulated, and 2 μCi (P20) of 14C-sucrose was injected (6 μL/g body weight) via the venous cannula, followed by an equal volume of saline. Blood was collected (60–80 μL) from the arterial cannula into heparinised glass capillaries every 5 minutes until the end of the experiment (30 minutes) and plasma separated by centrifugation. Immediately after the last blood sample was collected the heart was transected to prevent further circulation of the tracer and the brain dissected out. The brain was divided into the cerebral hemispheres, midbrain, cerebellum and brainstem and frozen.
Soluene-350 (0.5 mL, Packard Biosciences) was added to each vial with brain tissue and left for 48 hours at 37°C to completely solubilise the tissue. Following this, 4.5 mL of scintillation fluid (Ultra Gold, Packard Biosciences) was added to all vials with brain or plasma samples. The radioactivity in each vial was determined by liquid scintillation counting (1409 DSA, Wallac) and expressed as dpm/μg sample. Brain/plasma sucrose concentration ratios were calculated as has been described before . We have previously measured permeability in adult animals using the same treatment protocol and methods as for P20 animals , and data are presented along with the results from this study.
2.4. Claudin-5 Immunocytochemistry
LPS or saline-injected animals at P9, P20 and adult were terminally anaesthetised with inhaled isoflurane (P9) or i.p. Nembutal (P20 and adults; 0.1-0.2 mL/100 g, Rhone Merieux) before perfusion through the aorta with heparinised phosphate buffered saline (PBS, pH 7.4) followed by 4% paraformaldehyde in 0.1 M phosphate buffer (pH 7.4). Brains were removed from the skull, postfixed in Bouin’s fixative for 24 hours and processed and sectioned for histology. Briefly, tissue was dehydrated through increasing concentrations of ethanol, cleared in chloroform and embedded in paraffin wax. Sections were cut coronally with a thickness of 5 μm on a Bright rotary microtome (Leica) [5, 11].
Claudin-5 protein was detected in paraffin embedded tissue sections using the PAP method of immunohistochemistry. Sections were dewaxed, rehydrated and incubated in Peroxidase Blocker followed by Protein Blocker (1 hour each; Blockers sourced from DAKO). Sections were exposed to the primary antibody, mouse anticlaudin-5 (Zymed, diluted 1 : 200) overnight at 4°C. Secondary rabbit antimouse antibody and mouse-PAP (DAKO) were used following standard procedures  and sections developed for approximately 5 minutes using the DAB+ kit (DAKO). Between each incubation step, sections were washed minutes with PBS-Tween20 (pH 7.4). Controls included incubating slides with one of the antibodies omitted and were always blank.
Immunocytochemical distribution of claudin-5 in microvessels was determined under light microscope to be either “junctional” or “cytoplasmic” as described previously . The proportion of vessels with either appearance in the cortex and white matter (corpus callosum and external capsule) was determined and scored by the same blinded observer (KMD, 3–6 sections were counted per brain, brains in each group).
2.5. Electron Microscopy
For morphological examination of blood vessels with an electron microscope tissue was collected from adult rats exposed to either LPS or saline as neonates ( for each group). Animals were anaesthetised as described above and perfused transcardially with 50 mL heparinised phosphate buffered saline followed by 200 mL solution of 2% paraformaldehyde/2.5% glutaraldehyde in phosphate buffer (0.1 M, pH 7.3). Several tissue blocks (up to 1 mm3 a piece) were cut from different parts of the corpus callosum and external capsule from each animal and postfixed overnight in the same fixative. Tissue was washed in sodium cacodylate buffer (0.1 M, pH 7.3, minutes) before processing with a 2% osmium tetroxide/1% potassium ferricyanide solution followed by uranyl acetate treatment. Tissue was dehydrated in increasing concentrations of acetone and embedded in Araldite Epon. Ultrathin sections were cut with a Reichard UltraE microtome and contrasted with uranyl acetate and lead citrate. Thirty to fifty blood vessels from each tissue block were examined under a Phillips CM10 electron microscope to determine their ultrastructure with special focus on the integrity of tight junctions.
2.6. Statistical Analysis
Comparisons between saline-(control) and LPS-(experimental) injected animals were made using regression analysis for the prepulse inhibition test. For all other data, differences between control and experimental animal groups were compared for statistical significance using Student’s -tests with corrections for multiple comparisons. A -value of less than .05 was considered significant in all cases.
3.1. Behavioural Tests
The effect of systemic inflammation during early postnatal development of the rat on behaviour in later life was determined using behavioural tests previously shown to be associated with early life exposure to inflammation, such as anxiety (light/dark test) and altered prepulse inhibition (PPI) as well as general tests of motor behaviour and learning.
3.1.1. Prepulse Inhibition and Acoustic Startle Response
Acoustic startle response and prepulse inhibition were measured as part of one test. No significant difference in acoustic startle response was observed between LPS-treated or control animals at either P20 or adult (data not shown). However, a significant decrease in prepulse startle inhibition was observed in LPS-treated animals at P20 (linear regression analysis, **, Figure 1(a)). In adult animals there was a trend towards a decreased prepulse inhibition at the higher prepulse intensity (16 dB), the difference was not statistically significant (Figure 1(b)).
3.1.2. Light/Dark Test
P20 LPS-treated animals showed a small but significant decrease in their total moves in the Light/Dark test (*, Figure 2(a)) compared to those treated with saline. However, no changes in their entrance into the light half of the apparatus, the time spent in the light half or the latency to enter the light half was detected (Figures 2(b) and 2(c)). In contrast, in adult animals LPS treatment resulted in significantly increased entries into the light half of the apparatus as well as earlier entry and more time spent in the light half of the chamber (Figures 2(b) and 2(c)). They also showed generally more exploratory behaviour, as indicated by increased vertical plane entries (Figure 2(b)).
3.1.3. Open Field Exploration Test
LPS-treated adult rats showed no difference from control animals in any of the parameters analysed such as the total number of moves ( versus ), time (sec) moving ( versus ), or in their velocity (cm/sec, versus ).
3.1.4. Morris Water Maze
Adult animals exposed to LPS during their early postnatal development showed no significant differences in behaviour from the saline-injected controls in the Morris Water Maze, with no changes in the time taken to learn the location of a submerged platform or their exploratory behaviour when the platform was removed (Figures 3(a) and 3(b)).
3.2. Blood-Brain Barrier Permeability
Results from permeability studies performed in this paper are only valid within each age group and cannot be directly compared between P9 and older animals since different methods were used at different ages to determine brain/plasma sucrose concentration ratios (see Methods). Results are presented in Table 1. At P9 and P20 there was no significant difference in permeability of the blood-brain barrier between the LPS and saline-treated groups of animals. At P9 the brain/plasma sucrose concentration ratios of control animals were % (mean ± SEM) compared to % in LPS-treated animals (). At P20 the brain/plasma sucrose concentration ratios in controls were % compared to % () in LPS-treated animals (see Table 1). In contrast, in adult animals we have shown previously  there is a significant increase in the brain/plasma sucrose concentration ratios following early postnatal LPS treatment (% in LPS-treated animals compared to % for controls, *).
3.3. Claudin-5 Immunocytochemistry
Claudin-5 is so far the only tight junction protein that has been experimentally shown to directly affect the permeability of the blood-brain barrier , therefore its distribution was investigated using immunocytochemistry on paraffin-embedded brain sections (see Methods) and the results are illustrated and summarised in Figure 4. In saline-injected control animals at all ages studied (P9, P20 and adult), claudin-5 immunohistochemistry showed a typical cell-to-cell junction distribution pattern (Figures 4(a) and 4(c)) in approximately 80–100% of vessels (indicated as ++++ in Figure 4(e)) within the cortex and white matter while in the remaining cerebral blood vessels distribution of the claudin-5 immunoreactivity appeared more cytoplasmic. Distribution of claudin-5 immunoreactivity in brains from all LPS-treated animals showed a distinct shift, typically exhibiting less junctional staining and a relatively more cytoplasmic distribution (see Figures 4(b), 4(d), and 4(e)).
3.4. Ultrastructure of Cerebral Blood Vessels
The ultrastructure of blood vessels, and specifically tight junctions, in the white matter (external capsule and corpus callosum) was examined. Tissue was compared from adult control animals and adult animals that had been exposed to LPS during development. All vessels examined from control brains appeared to have a normal ultrastructure, with little perivascular space, close association of astrocytic end feet, well defined basement membrane (Figure 5(a)) and obvious tight junctions between the intercellular clefts of apposing endothelial cells (Figure 5(c)). Most vessels in white matter from LPS-treated animals were not obviously different from control brains (Figure 5(b)). Tight junctions were apparent at cell-cell contacts (Figure 5(d)), as were the associations with the surrounding structures. However, in 2 out of 50 vessels in sections from the LPS-treated animals, ultrastructural abnormalities were observed (Figure 5(e)). In these vessels the lumen was convoluted and there was an apparent disruption of the perivascular space. Despite this, the structure of the tight junctions associated with these unusual vessels appeared to be normal (Figure 5(f)).
Increasing evidence, both clinical and experimental, indicates that an early inflammatory insult can affect brain development and behaviour later in life. The aim of this study was to determine whether there is a correlation between changes in the permeability properties of the blood-brain barrier induced by a period of neonatal inflammation and later behaviour using the rat as an experimental model.
4.1. Blood-Brain Barrier Permeability and Behaviour
In the present model of early life inflammation some alterations in blood-brain barrier function and white matter damage have previously been reported. These include short-term changes in blood-brain barrier permeability to protein in young pups and long-term changes to small molecular weight molecules in adult animals exposed to prolonged inflammation during development . The present study determined that this long-term permeability change develops sometime after 3 weeks of age, as animals tested at P20 showed no significant change in the permeability of the blood-brain barrier to sucrose (Table 1). Interestingly, changes in blood vessel tight junction distribution preceded long-term alterations in both blood-brain barrier permeability and behaviour.
It has previously been hypothesised that this alteration in function of the blood-brain barrier in the adult may contribute to inflammation-induced behavioural changes such as altered prepulse inhibition (PPI). The results from the current study suggest that changes in PPI occur prior to the long-term change in barrier function to small molecules, however they may relate to damage resulting from the transient increase in protein permeability and white matter volume reduction that occurs up to P9 .
One of the major behavioural modifications observed in the present study was a change in sensory-motor gaiting, demonstrated by PPI test in juvenile rats, but not in adults following an early inflammatory insult (Figure 1). Changes in PPI have been reported in several studies that examined effects of systemic inflammation during fetal or early postnatal stages of brain development, however, some results have been conflicting. Fortier and colleagues  found that LPS administered to pregnant mice during mid to late gestation resulted in reduced PPI in offspring when adult, whereas polyI:C, which is used to mimic viral infections, did not. In contrast, higher doses of polyI:C at comparable ages of gestation have been found to result in altered PPI in a separate study . Similarly, Fortier et al.  suggested that inflammation at very early stages of gestation (GD10-11) in the mouse did not cause changes in the PPI response of the adult offspring, while an earlier study by Shi et al.  indicated that inflammation-induced either by viral infection or injection of the polyI:C viral mimic at GD9.5 did in fact result in a reduced PPI response in adult offspring. These discrepancies could be due to the different doses of polyI:C used, particularly as inflammation has been associated with increased serum cortisol concentration in the perinatal period , which in turn has been found to alter PPI in a dose-specific manner . This suggests that these two systems may interact to produce widely different results depending on the magnitude of the initial insult. Therefore, while changes in PPI are now frequently seen in models of early life inflammatory challenge, the long-term behavioural outcome is dependent on many factors, including dose of inflammatory agent and gestational age at time of insult. The present study supports the recent finding of Ibi et al.  that neonatal inflammation, in comparison to inflammation during gestation, also results in long-term alteration in the PPI response. It also supports the hypothesis of Wolff and Bilkey  that PPI deficits are distinguishable in juvenile animals.
Behavioural changes seen at P20 for PPI may continue into adulthood although in this study the difference between the two treatment groups was no longer statistically significant (Figure 1). LPS challenged animals did however show a significant behavioural change in the Light/Dark test compared to saline-treated animals when adult (Figure 2). In contrast, in animals tested at P20 there was no significant difference for this test between control and LPS-injected animals suggesting that the effect seen in adult animals may take a longer period to develop and is not manifested until later in life. However, it may be that this is not an appropriate test for such juvenile animals, as many of them (both saline- and LPS-injected) did not enter the light area of the arena at all during the testing period.
The results of the Light/Dark test obtained for adult animals were different from what might have been expected from clinical disease associations [28, 29] and some previous studies. Fetal exposure to inflammation (via the dam) in the C57 mouse produced long-term anxiety-like behaviour on the elevated plus maze . However, a study of inflammation in the postnatal rat (P7-28) did not show any increased anxiety-like behaviour on the same apparatus [31, 32]. The reduced light avoidance exhibited by the LPS-treated animals in the present study (Figure 2) does not appear to be due to reduced sensory input. Animals receiving LPS-injections during infancy responded normally to visual and auditory stimuli in the Morris Water Maze and PPI. It therefore seems that much of the apparent conflict in results so far reported in the literature may reflect differences in timing of inflammation during development, the degree of inflammatory insult, the method of inducing it and perhaps the species.
LPS-treated animals showed no difference in their behaviour compared to saline-injected control animals for either the open field or the Morris Water Maze, indicating that not all aspects of behaviour are affected as a result of inflammatory insult during early postnatal development.
4.2. Tight Junctions
We examined tight junctions both morphologically under the electron microscope and molecularly using claudin-5 immunoreactivity. Tight junctions located between endothelial cells of cerebral blood vessels are the structural basis for the blood-brain barriers that normally severely restrict paracellular permeability from blood into brain . The present study of blood vessel ultrastructure in the white matter of adult animals exposed to LPS early in development showed no apparent alteration in the structure of tight junctions with several “kissing points” visible as an indicator of closely apposed membranes.
However, while examining these junctions we found a small number of the blood vessels that did appear to have gross ultrastructural abnormalities (Figure 5). The gross ultrastructural changes observed in these vessels are not dissimilar to those observed in animal models of pericyte deficiency  where increased permeability of the blood-brain barrier was observed. Although the proportion of these abnormal vessels was low this does not rule out their potential to influence blood-brain barrier permeability. Due to the normally extremely low permeability of cerebral blood vessels, a few vessels with altered permeability could significantly contribute to the overall properties of the blood-brain barrier. Although the tight junctions in all vessels appeared to be normal (including those in the abnormal vessels, Figure 5), the functionality of these tight junctions can only be confirmed using electron denser tracers . Sucrose permeability was increased throughout the cortex in these animals, indicating that other low molecular weight molecules, such as some drugs or heavy metals, may have prolonged access to the brain, potentially contributing to long-term damage of the brain.
The tight junctions are composed of a number of proteins that are thought to have different roles in relation to paracellular permeability. Disruption of these proteins has been associated with alterations in blood-brain barrier permeability [36–38] and the expression of, for example, claudin-5 can be regulated through protein kinase C by the actions of a number of cytokines . Molecular alterations of the tight junction proteins may lead to increased permeability even without ultrastructurally altering the junctions. In a claudin-5 knockout mouse no overt morphological abnormalities in the blood vessels were found despite a size selective increase in blood-brain barrier permeability ; however, as this study did not include EM immunocytochemistry it is not clear what was the cellular route (paracellular or transcellular) responsible for the observed increase in barrier permeability to small molecules that was observed. Although there is a link between altered claudin-5 distribution and an increase in sucrose permeability in adults in the present study (Table 1), the results from younger animals show that LPS treatment can also cause an altered distribution of claudin-5 protein immunoreactivity that is not associated with changes in sucrose permeability. In order to understand these differences we need a better understanding of the molecular functions of tight junction proteins as well as the changes of these proteins that may occur in response to LPS treatment.
In conclusion, the present results demonstrate that a period of prolonged systemic inflammation in the neonatal rat can cause a multitude of modifications that manifest in later life, ranging from alterations in behaviour, changes in blood-brain barrier permeability and in structure of some cerebral blood vessels. The results also show that these changes develop at different times after the initiating inflammatory insult and are not always temporally correlated. The results from the present study are suggestive of a two-phase progression model: a first wave of damage (i.e., acute blood-brain barrier disruption and white matter damage ) that causes early changes in blood vessel morphology/composition and early behavioural alterations and a second phase of damage, induced by the adult-onset increase in blood-brain barrier permeability, that produces the later behavioural changes.
This work was supported by an NHMRC project grant. H. B. Stolp, M. D. Habgood, K. M. Dziegielewska, N. R. Saunders, and C. J. Ek are members of the Neurobid Consortium, funded by the NHMRC and European Union Seventh Framework Programme (FP7/2007-2013) under Grant agreement no. HEALTH-F2-2009-241778.
- A. S. Brown, “Prenatal infection as a risk factor for schizophrenia,” Schizophrenia Bulletin, vol. 32, no. 2, pp. 200–202, 2006.
- K. B. Nelson and R. E. Willoughby, “Infection, inflammation and the risk of cerebral palsy,” Current Opinion in Neurology, vol. 13, no. 2, pp. 133–139, 2000.
- C. A. Pardo and C. G. Eberhart, “The neurobiology of autism,” Brain Pathology, vol. 17, no. 4, pp. 434–447, 2007.
- H. B. Stolp and K. M. Dziegielewska, “Review: role of developmental inflammation and blood-brain barrier dysfunction in neurodevelopmental and neurodegenerative diseases,” Neuropathology and Applied Neurobiology, vol. 35, no. 2, pp. 132–146, 2009.
- H. B. Stolp, K. M. Dziegielewska, C. J. Ek et al., “Breakdown of the blood-brain barrier to proteins in white matter of the developing brain following systemic inflammation,” Cell and Tissue Research, vol. 320, no. 3, pp. 369–378, 2005.
- T. Debillon, C. Gras-Leguen, S. Leroy, J. Caillon, J. C. Rozé, and P. Gressens, “Patterns of cerebral inflammatory response in a rabbit model of intrauterine infection-mediated brain lesion,” Developmental Brain Research, vol. 145, no. 1, pp. 39–48, 2003.
- F. H. Gilles, D. R. Averill, and C. S. Kerr, “Neonatal endotoxin encephalopathy,” Annals of Neurology, vol. 2, no. 1, pp. 49–56, 1977.
- C. Mallard, A. K. Welin, D. Peebles, H. Hagberg, and I. Kjellmer, “White matter injury following systemic endotoxemia or asphyxia in the fetal sheep,” Neurochemical Research, vol. 28, no. 2, pp. 215–223, 2003.
- Y. Pang, Z. Cai, and P. G. Rhodes, “Disturbance of oligodendrocyte development, hypomyelination and white matter injury in the neonatal rat brain after intracerebral injection of lipopolysaccharide,” Developmental Brain Research, vol. 140, no. 2, pp. 205–214, 2003.
- C. I. Rousset, S. Chalon, S. Cantagrel et al., “Maternal exposure to LPS induces hypomyelination in the internal capsule and programmed cell death in the deep gray matter in newborn rats,” Pediatric Research, vol. 59, no. 3, pp. 428–433, 2006.
- H. B. Stolp, K. M. Dziegielewska, C. J. Ek, A. M. Potter, and N. R. Saunders, “Long-term changes in blood-brain barrier permeability and white matter following prolonged systemic inflammation in early development in the rat,” European Journal of Neuroscience, vol. 22, no. 11, pp. 2805–2816, 2005.
- X. Wang, G. Hellgren, C. Löfqvist et al., “White matter damage after chronic subclinical inflammation in newborn mice,” Journal of Child Neurology, vol. 24, no. 9, pp. 1171–1178, 2009.
- G. Loron, P. Olivier, H. See, et al., “Ciprofloxacin prevents myelination delay in neonatal rats subjected to E. coli sepsis,” Annals of Neurology. In press.
- L. W. Fan, Y. Pang, S. Lin, P. G. Rhodes, and Z. Cai, “Minocycline attenuates lipopolysaccharide-induced white matter injury in the neonatal rat brain,” Neuroscience, vol. 133, no. 1, pp. 159–168, 2005.
- U. Meyer, M. Nyffeler, A. Engler et al., “The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology,” Journal of Neuroscience, vol. 26, no. 18, pp. 4752–4762, 2006.
- L. Shi, S. E. P. Smith, N. Malkova, D. Tse, Y. Su, and P. H. Patterson, “Activation of the maternal immune system alters cerebellar development in the offspring,” Brain, Behavior, and Immunity, vol. 23, no. 1, pp. 116–123, 2009.
- M. E. Fortier, G. N. Luheshi, and P. Boksa, “Effects of prenatal infection on prepulse inhibition in the rat depend on the nature of the infectious agent and the stage of pregnancy,” Behavioural Brain Research, vol. 181, no. 2, pp. 270–277, 2007.
- L. Shi, S. H. Fatemi, R. W. Sidwell, and P. H. Patterson, “Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring,” Journal of Neuroscience, vol. 23, no. 1, pp. 297–302, 2003.
- Y. Pang, L. W. Fan, B. Zheng, Z. Cai, and P. G. Rhodes, “Role of interleukin-6 in lipopolysaccharide-induced brain injury and behavioral dysfunction in neonatal rats,” Neuroscience, vol. 141, no. 2, pp. 745–755, 2006.
- S. D. Bilbo, J. C. Biedenkapp, A. Der-Avakian, L. R. Watkins, J. W. Rudy, and S. F. Maier, “Neonatal infection-induced memory impairment after lipopolysaccharide in adulthood is prevented via caspase-1 inhibition,” Journal of Neuroscience, vol. 25, no. 35, pp. 8000–8009, 2005.
- K. Morita, H. Sasaki, M. Furuse, and S. Tsukita, “Endothelial claudin: claudin-5/TMVCF constitutes tight junction strands in endothelial cells,” Journal of Cell Biology, vol. 147, no. 1, pp. 185–194, 1999.
- T. Nitta, M. Hata, S. Gotoh et al., “Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice,” Journal of Cell Biology, vol. 161, no. 3, pp. 653–660, 2003.
- C. J. Ek, M. D. Habgood, K. M. Dziegielewska, A. Potter, and N. R. Saunders, “Permeability and route of entry for lipid-insoluble molecules across brain barriers in developing Monodelphis domestica,” Journal of Physiology, vol. 536, no. 3, pp. 841–853, 2001.
- A. R. Wolff and D. K. Bilkey, “Immune activation during mid-gestation disrupts sensorimotor gating in rat offspring,” Behavioural Brain Research, vol. 190, no. 1, pp. 156–159, 2008.
- R. E. Fisher, N. A. Karrow, M. Quinton et al., “Endotoxin exposure during late pregnancy alters ovine offspring febrile and hypothalamic-pituitary-adrenal axis responsiveness later in life,” Stress, vol. 13, no. 4, pp. 334–342, 2010.
- S. L. Kjær, G. Wegener, R. Rosenberg, S. P. Lund, and K. S. Hougaard, “Prenatal and adult stress interplay—behavioral implications,” Brain Research, vol. 1320, pp. 106–113, 2010.
- D. Ibi, T. Nagai, Y. Kitahara et al., “Neonatal polyI:C treatment in mice results in schizophrenia-like behavioral and neurochemical abnormalities in adulthood,” Neuroscience Research, vol. 64, no. 3, pp. 297–305, 2009.
- N. Davies, A. Russell, P. Jones, and R. M. Murray, “Which characteristics of schizophrenia predate psychosis?” Journal of Psychiatric Research, vol. 32, no. 3-4, pp. 121–131, 1998.
- M. Weinstock, “Alterations induced by gestational stress in brain morphology and behaviour of the offspring,” Progress in Neurobiology, vol. 65, no. 5, pp. 427–451, 2001.
- G. Hava, L. Vered, M. Yael, H. Mordechai, and H. Mahoud, “Alterations in behavior in adult offspring mice following maternal inflammation during pregnancy,” Developmental Psychobiology, vol. 48, no. 2, pp. 162–168, 2006.
- S. J. Spencer, J. G. Heida, and Q. J. Pittman, “Early life immune challenge—effects on behavioural indices of adult rat fear and anxiety,” Behavioural Brain Research, vol. 164, no. 2, pp. 231–238, 2005.
- S. J. Spencer, S. Martin, A. Mouihate, and Q. J. Pittman, “Early-life immune challenge: defining a critical window for effects on adult responses to immune challenge,” Neuropsychopharmacology, vol. 31, no. 9, pp. 1910–1918, 2006.
- T. S. Reese and M. J. Karnovsky, “Fine structural localization of a blood-brain barrier to exogenous peroxidase,” Journal of Cell Biology, vol. 34, no. 1, pp. 207–217, 1967.
- P. Lindahl, B. R. Johansson, P. Levéen, and C. Betsholtz, “Pericyte loss and microaneurysm formation in PDGF-B-deficient mice,” Science, vol. 277, no. 5323, pp. 242–245, 1997.
- C. J. Ek, K. M. Dziegielewska, H. Stolp, and N. R. Saunders, “Functional effectiveness of the blood-brain barrier to small water-soluble molecules in developing and adult opossum (Monodelphis domestica),” Journal of Comparative Neurology, vol. 496, no. 1, pp. 13–26, 2006.
- N. S. Harhaj and D. A. Antonetti, “Regulation of tight junctions and loss of barrier function in pathophysiology,” International Journal of Biochemistry and Cell Biology, vol. 36, no. 7, pp. 1206–1237, 2004.
- M. A. Petty and E. H. Lo, “Junctional complexes of the blood-brain barrier: permeability changes in neuroinflammation,” Progress in Neurobiology, vol. 68, no. 5, pp. 311–323, 2002.
- B. Engelhardt and L. Sorokin, “The blood-brain and the blood-cerebrospinal fluid barriers: function and dysfunction,” Seminars in Immunopathology, vol. 31, no. 4, pp. 497–511, 2009.
- Y. Sonobe, H. Takeuchi, K. Kataoka et al., “Interleukin-25 expressed by brain capillary endothelial cells maintains blood-brain barrier function in a protein kinase Cε-dependent manner,” Journal of Biological Chemistry, vol. 284, no. 46, pp. 31834–31842, 2009.